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The extent to which humans and wildlife are exposed to the vast array of anthropogenic chemicals and their
degradation products, along with related naturally occurring compounds, is nowadays an important issue.
The study of the physical-chemical properties of the compounds and/or degradation products is an important
subject because some of them are intrinsically related to its resistance to degradation and/or bioaccumulation.
Accordingly, the study of the electrochemical behavior of the selective serotonin reuptake inhibitor fluoxetine
and its main metabolite norfluoxetine was investigated. The identification of the oxidation processes was
done via two fluoxetine analogues, 1-(benzyloxy)-4-(trifluoromethyl)benzene and N-methyl-3-phenylpropan-
1-amine hydrochloride. The oxidative processes occurring in fluoxetine are pH-dependent and were ascribed
to the chemical moieties present in the molecule: the secondary amine group and the substituted aromatic
nucleus. To perform an unequivocal ascription, the structural preferences of the drug and metabolite were
also determined, by Raman spectroscopy coupled to quantum mechanical calculations (at the DFT level).
The analytical data obtained in this work will allow the development of a rapid and unequivocal spectroscopic
procedure suitable for fluoxetine identification, as well as to distinguish between the drug and its main
metabolite.
Introduction
In the past decade, fluoxetine (N-methyl-γ-[4-(trifluorom-
ethyl)phenoxy]benzene-propanamine, Scheme 1) has emerged
as one of the most frequently prescribed antidepressants
(marketed with diverse trade names such as Prozac) and has
received a great deal of attention. Fluoxetine belongs to a
group of medicines known as selective serotonin reuptake
inhibitors (SSRIs) that are thought to work by increasing the
activity of serotonin in the brain. Fluoxetine is commercial-
ized as a racemic mixture whereby the S-enantiomer is
approximately 1.5 times more potent than the R-enantiomer
in the inhibition of serotonin reuptake.1 The conformational
characteristics of the fluoxetine highly influence its neu-
rotransmitter role and selectivity, namely the folded orienta-
tion of the [(trifluoromethyl)phenoxy] moiety relative to the
amine chain. It is generally accepted that the p-trifluoromethyl
substituent contributes either for its potency or for its
selectivity, neuropharmacological action.2 This information
could be connected to the lipophilicity and electron-
withdrawing properties of the substituent. Fluoxetine under-
goes extensive metabolic conversion, leading to an active
metabolite, norfluoxetine (Scheme 1), followed in a somewhat
lower proportion by conjugated or sulfate derivatives.
Recently, fluoxetine and its major metabolite have become a
topic of growing public concern. These compounds have been
detected in a number of environmental water samples including
wastewaters effluents, rivers, and streams.3-5 Some studies have
suggested there could be a range of potential aquatic ecosystem
effects of these compounds in the environment.6 In fact,
fluoxetine and norfluoxetine have been detected in fish samples
obtained from an effluent-dominated stream, this information
being an indicator of their bioaccumulation potential.7,8 Although
bioaccumulation is usually a pH-dependent phenomenon,8-10
little research has been addressed toward the study of the pH
effects on pharmaceutical drugs bioaccumulation. The same
concern is related to the scarce number of metabolism and
toxicity studies of this type of organic micropollutants in the
environment. So, this subject is nowadays considered an
emergent society problem that could be minimized through an
intensive investigation in the area.
Accordingly, this work emerges as a contribution to
increase the knowledge of the environment fate of fluoxetine
throughout the study of its metabolic oxidative pathways and
a complete conformational characterization of the drug and
its main metabolite, norfluoxetine (Scheme 1). Therefore, a
detailed electrochemical study of fluoxetine and norfluoxetine
was performed, in a broad pH range, using different volta-
mmetric techniques. The identification of the oxidation
processes was done by analogy-based electrochemical be-
havior of two synthesized fluoxetine analogues, 1-(benzyl-
oxy)-4-(trifluoromethyl)benzene and N-methyl-3-phenylpro-
pan-1-amine hydrochloride (Scheme 1). Furthermore, a
thorough conformational analysis of fluoxetine and norflu-
oxetine was performed, by Raman spectroscopy coupled to
quantum mechanical calculations (at the Density Functional
Theory (DFT) level), which enabled us to obtain detailed
knowledge of the structural characteristics and the vibrational
behavior.
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Experimental Methods
Reagents. Fluoxetine and norfluoxetine hydrochlorides were
kindly provided by Lilly Farma (Lisbon, Portugal).
N-Deuterated fluoxetine was obtained by mixing the drug with
D2O (ca. 10% excess). The remaining D2O was distilled under
reduced pressure. The process was repeated at least three times
(until no νNH bands were detected in the Raman spectrum).
4-(Trifluoromethyl)phenol, potassium carbonate, benzyl chlo-
ride, hydrocinnamaldehyde, methylammonium chloride, sodium
cyanoborohydride, and anhydrous solvents were purchased from
Sigma-Aldrich Quı´mica S.A. (Sintra, Portugal). Analytical grade
reagents purchased from Merck (Darmstadt, Germany) were
used without additional purification. Deionized water (conduc-
tivity <0.1 µS cm-1) was used throughout the experiments.
Buffer solutions employed for voltammetric determinations were
0.2 M in the pH range 1.2-12.2.
Synthesis. Structural Elucidation. 1H and 13C NMR data
were acquired at room temperature, on a Bru¨ker AMX 300
spectrometer operating at 300.13 and 75.47 MHz, respectively.
Dimethylsulfoxide-d6 and deuterated chloroform were used as
a solvent; chemical shifts are expressed in δ (ppm) values
relative to tetramethylsilane (TMS) as internal reference;
coupling constants (J) are given in Hz. Electron impact mass
spectra (EI-MS) were carried out on a VG AutoSpec instrument;
the data are reported as m/z (% of relative intensity of the most
important fragments). Melting points were obtained on a Ko¨fler
microscope (Reichert Thermovar) and are uncorrected.
Chromatographic Conditions. The analytical control was
performed by thin-layer chromatography (TLC) on plates
precoated with silica gel 60 F254 as stationary phase (0.2 mm
as layer thickness). The spots were visualized under UV
detection (254 and 366 nm) and iodine vapor.
The purity of the final products (>98% purity) was verified
using a high-performance liquid chromatography (HPLC)
system equipped with UV detector. HPLC-UV chromatograms
were obtained in a Jasco instrument (pumps model 880-PU and
solvent mixing model 880-30, Tokyo, Japan), equipped with a
Nucleosil RP-18 column (250 mm × 4.6 mm, 5 µm, Macherey-
Nagel, Du¨ren, Germany), and UV detection at 230 nm (Jasco
model 875-UV). pH 3 phosphate buffer/methanol (6:1) was used
as the mobile phase, in isocratic flow rate of 1.2 mL/min. The
chromatographic data were processed in a Compaq computer,
fitted with CSW 1.7 software (DataApex, Czech Republic).
Synthesis of 1-(Benzyloxy)-4-(trifluoromethyl)benzene. 4-(Tri-
fluoromethyl)phenol (1.0 g, 6.2 mmol) was dissolved in N,N-
dimethylformamide (DMF) (15 mL). Potassium carbonate (3.5
g, 24.3 mmol) and benzyl chloride (0.9 mL, 7.8 mmol) were
then added to the solution. The resulting suspension was stirred
and refluxed for 5 h. After that the solids were filtered off and
the solution was poured into ice. After acidification with HCl
(pH 4), a white precipitate was produced. The product was
filtered, washed with cold water, and identified as 1-(benzyloxy)-
4-(trifluoromethyl)benzene.
Yield 96%. 1H NMR (DMSO) δ: 5.20 (2H, s), 7.18 (1H, d,
J ) 0.9), 7.21 (1H, d, J ) 0.9), 7.34-7.47 (5H, m), 7.64 (1H,
d, J ) 0.9), 7.67 (1H, d, J ) 0.9). 13C NMR δ: 69.5 (CH2),
115.3 (CH), 126.9 (CH), 127.0 (CH), 127.8 (CH), 128.0 (CH),
128.5 (CH), 136.4 (C), 161.2 (C). EI-MS m/z (%): 252, 233,
183, 161, 145, 133, 113, 91, 65.
Synthesis of N-Methyl-3-phenylpropan-1-amine Hydrochlo-
ride. Sodium cyanoborohydride (1.2 g, 20 mmol) was added to
a solution of hydrocinnamaldehyde (2.0 g, 15 mmol) and
methylammonium chloride (10.1 g, 150 mmol) in 50 mL of
methanol, under nitrogen atmosphere. The resulting mixture was
stirred for 8 h. Hydrochloric acid was added from time to time
to keep the pH between 5 and 6. After that the solution was
poured into 600 mL of dilute hydrochloric acid. The acidic layer
was then basified with 30% sodium hydroxide and extracted
with dichloromethane. The organic layer was dried over Na2SO4,
filtered, and the solvent was evaporated. The resulting oil was
SCHEME 1: Chemical Structures of the Studied Compounds
Fluoxetine and Norfluoxetine Revisited J. Phys. Chem. A, Vol. 113, No. 36, 2009 9935
D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
D
A
D
E 
D
E 
CO
IM
BR
A
 o
n 
Se
pt
em
be
r 7
, 2
00
9 
| ht
tp:
//p
ub
s.a
cs.
org
 
 
Pu
bl
ic
at
io
n 
D
at
e 
(W
eb
): 
Au
gu
st 
17
, 2
00
9 | 
doi
: 1
0.1
021
/jp
904
306
b
dissolved in acidic methanol (HCl), and diethyl ether was added
until insolubilization. The white solid was filtered, washed, and
identified as N-methyl-3-phenylpropan-1-amine hydrochloride.
Yield 40%. 1H NMR (CDCl3) δ: 1.99-2.08 (2H, m), 2.45
(3H, s), 2.57-2.52 (2H, m), 2.76-2.70 (2H, m), 7.13-6.99
(5H, m), 9.42 (2H, brs). 13C NMR δ: 30.9 (CH2), 33.2 (CH2),
35.8 (CH3), 50.9 (CH2), 125.5 (CH), 128.1 (CH), 128.2 (CH),
142.0 (C). EI-MS m/z (%): 149, 134, 118, 91.
Electrochemical Studies. Voltammetric measurements were
performed using an Autolab PGSTAT 12 potentiostat/gal-
vanostat (EcoChimie, Netherlands) electrochemical analyzer. A
glassy carbon working electrode (Metrohm; diameter: 2 mm),
an Ag/AgCl reference electrode (Metrohm; 3 M KCl), a glassy
carbon rod counter electrode (Metrohm), and a standard one-
compartment three-electrode cell were used in all experiments.
The working electrode was polished manually with an aqueous
slurry of alumina powder (BDH) on a microcloth pad and rinsed
with water before use. All measurements were made at room
temperature.
A Crison pH-meter with glass electrode was used for the pH
measurements (Crison, Spain).
DFT Calculations. The quantum mechanical calculations
were performed using the Gaussian 03W program,11 within the
Density Functional Theory (DFT) approach. The widely em-
ployed hybrid method denoted by B3LYP, which includes a
mixture of HF and DFT exchange terms and the gradient-
corrected correlation functional of Lee, Yang and Parr,12,13 as
proposed and parametrized by Becke,14,15 was used, along with
the double- split valence basis set 6-31G**.16
Molecular geometries were fully optimized by the Berny
algorithm, using redundant internal coordinates:17 the bond
lengths to within ca. 0.1 pm and the bond angles to within ca.
0.1°. The final root-mean-square (rms) gradients were always
less than 3 × 10-4 hartree bohr-1 or hartree radian-1. No
geometrical constraints were imposed on the molecules under
study.
The harmonic vibrational wavenumbers, as well as the Raman
activities and infrared intensities, were calculated at the same
level of theory, yielding the corresponding calculated vibrational
pattern. Frequencies above 400 cm-1 were scaled by a factor
of 0.961418 before comparing them with the experimental data,
to correct for the anharmonicity of the experimental normal
modes of vibration.
Figure 1. (a) 3D plot and (b) plot of Ep vs pH from differential pulse
voltammograms of 0.2 mM solutions of fluoxetine in different buffer
electrolytes as a function of pH. Scan rate 5 mV s-1.
Figure 2. Differential pulse voltammograms of (a) 0.2 mM solution
of fluoxetine at ( · · · ) pH 8 and (-) pH 9 buffer electrolyte and (b)
0.2 mM solutions of (-) fluoxetine, (- - -) N-methyl-3-phenylpropan-
1-amine hydrochloride, and ( · · · ) 1-(benzyloxy)-4-(trifluoromethyl)-
benzene in pH 8 buffer electrolyte. Scan rate 5 mV s-1.
SCHEME 2: Proposed Mechanism for the
Electrochemical Oxidation of Fluoxetine
9936 J. Phys. Chem. A, Vol. 113, No. 36, 2009 Garrido et al.
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Raman Spectroscopy. The Raman spectra were collected
for the solid compounds, at room temperature, on a triple
monochromator Jobin-Yvon T64000 Raman system (focal
distance 0.640 m, aperture f/7.5) equipped with holographic
gratings of 1800 grooves mm-1. The premonochromator stage
was used in the subtractive mode. The detection system was a
liquid nitrogen cooled nonintensified 578 × 385 pixel (1/2”)
charge coupled device (CCD) chip. A Coherent (model Innova
300-05) Ar+ laser was used as light source, the output of which
at 514.5 nm was adjusted to provide 90 mW at the sample
position. A 90° geometry, between the incident radiation and
the collecting system, was employed. The entrance slit was set
to 200 µm, and the slit between the premonochromator and the
spectrograph was opened to 12 mm. An integration time of 5 s
and 30-50 scans were used in all experiments. Samples were
sealed in Kimax glass capillary tubes of 0.8 mm inner diameter.
Under the above-mentioned conditions, the error in wavenum-
bers was estimated to be within 1 cm-1.
Results and Discussion
Chemistry. Different synthetic strategies were used to obtain
1-(benzyloxy)-4-(trifluoromethyl)benzene and N-methyl-3-phe-
nylpropan-1-amine hydrochloride. The first model compound
was obtained by an O-benzylation reaction of 4-(trifluorom-
ethyl)phenol in basic medium.19 As the other model compound
is functionally a methyl amine derivative, it was believed that
the suitable synthetic strategy could be related to the obtention
of a precursor with a primary amine function that could be
subsequently N-alkylated. However, the N-alkylation of a
primary amine is frequently regarded as a slow and unclean
process that results in a mixture of the secondary and tertiary
amines as side compounds. Because of the mentioned synthetic
difficulties, an indirect alkylation process was chosen to obtain
N-methyl-3-phenylpropan-1-amine hydrochloride. The method
seemed to be an attractive approach because it corresponds to
a one-pot reaction in which an aldehyde (hydrocinnamaldehyde)
is treated with methylammonium chloride in the presence of
sodium cyanoborohydride. In fact, the reductive amination of
the carbonyl function led to the pretended compound in an
excellent yield.20,21 The structural elucidation of the compounds
was performed by FT-IR, NMR, and EM and is presented in
the Experimental Methods.
Electrochemical Studies. To understand fluoxetine oxidation
pathways and to assess the influence of pH on its oxidative and
degradation profile, a comprehensive study on the electrochemi-
cal properties of this molecule was therefore carried out, in a
broad pH range (1.2-12.2), at a glassy carbon electrode, using
different voltammetric techniques.
The differential pulse voltammetric (DPV) behavior of
fluoxetine yielded one anodic wave, Ep ) +1.20 V, starting at
pH 5 (Figure 1a). As the pH increased, the anodic wave
observed starting at pH 9, Ep ) +0.86 V, appears to be the
result of the sum of two close peaks (Figure 1a). In fact, a well-
defined shoulder prior to the main peak is observed, meaning
Figure 3. (a) 3D plot and (b) plot of Ep vs pH from differential pulse
voltammograms of 0.2 mM solutions of 1-(benzyloxy)-4-(trifluorom-
ethyl)benzene in different buffer electrolytes as a function of pH. Scan
rate 5 mV s-1.
Figure 4. (a) 3D plot and (b) plot of Ep vs pH from differential pulse
voltammograms of 0.2 mM solutions of N-methyl-3-phenylpropan-1-
amine hydrochloride in different buffer electrolytes as a function of
pH. Scan rate 5 mV s-1.
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that the two peaks are almost superimposed (Figure 2a). On
the basis of the literature and author’s electrochemical expertise
on this type of compounds, it was assumed that the main
oxidative process, starting at pH 5, occurs due to the existence
of a secondary amine group, and the second oxidation signal is
a result of an oxidation occurring on the aromatic nucleus that
bears the p-trifluoromethyl substituent (Schemes 1 and 2).22,23
The peak potential (Ep) of the oxidation process moved to less
positive potential when raising the pH (Figure 1b). At pH higher
than 10, the electrode process is pH-independent. The intercep-
tion point observed at pH 10 can be attributed to the ionization
constant of fluoxetine. This is in accordance with the pKa
described in the literature (pKa ) 10.18).
To better comprehend the oxidative profile and to establish
an unequivocal identification of the oxidation processes occur-
ring, the voltammetric assessment was extended to the study
of two fluoxetine analogues, 1-(benzyloxy)-4-(trifluoromethyl)-
benzene and N-methyl-3-phenylpropan-1-amine hydrochloride
(Scheme 1), obtained by analogy-based synthetic design.
Excluding the peak observed at +0.35 V for pH 3-4, which
is related to the GCE background current, the DPV behavior of
1-(benzyloxy)-4-(trifluoromethyl)benzene yielded a single an-
odic wave, Ep ) +1.05 V, starting at pH 3 (Figure 3a). The
peak potential (Ep) is pH-dependent, because a decrease was
observed upon pH increment (Figure 3b). At pH 7 and 8, a
second poorly resolved wave is seen at Ep ) +1.40 V.
Considering the molecular structure, it is reasonable to assume
that the main oxidation peak observed could only be ascribed
to the unique function present in the molecule susceptible to
be oxidized, the oxygen aromatic ether. Previous work on similar
alkoxybenzenes and literature data indicated that the oxidation
process proceeds at the aromatic nucleus, through a one-electron
transfer, via the formation of an unstable cation-radical inter-
mediate that could undergo further subsequent reactions.24-27
Figure 5. Schematic representation of the most stable conformers calculated for fluoxetine (A), N-protonated fluoxetine (B), and N-protonated
norfluoxetine (C) (B3LYP/6-31G** level of calculation; the atom numbering for fluoxetine is included, according to that previously used in X-ray
studies of the molecule31).
9938 J. Phys. Chem. A, Vol. 113, No. 36, 2009 Garrido et al.
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The second poorly resolved wave observed at pH 7 and 8, not
detected for fluoxetine, must then be related to the oxidation of
the species resulting from the formation and dimerization of
the initial cation radical (Scheme 2).25,27 As this moiety is present
in fluoxetine (Scheme 1), it seems reasonable to infer that the
pharmaceutical drug shares the same oxidation pattern. More-
over, the results observed for this analogue, and in particular
the evidence of the formation of dimeric species, could
contribute to explain the strong adsorption processes that occur
when using glassy carbon electrodes for measuring fluoxetine,
which is perhaps the main reason for the limited use of
electrochemical methods for its quantification.28,29
The DPV study of the other model compound N-methyl-3-
phenylpropan-1-amine hydrochloride yielded an anodic wave,
Ep ) +1.00 V, starting at pH 7 (Figure 4a). The aliphatic
secondary amine present in the molecule structure must be
responsible for the oxidative behavior found for this compound.
Actually, other aliphatic amines described in the literature
disclose a similar oxidation peak at this Ep value.22,30 The peak
potential (Ep)-pH plot of this N-methylamine (Figure 4b) shows
two linear segments, indicating that the electrode process is pH-
dependent. The break in the Ep-pH plot can be ascribed to the
changes in protonation of the amine group present in the
molecule. From the intersection point, it is possible to deduce
the N-methyl-3-phenylpropan-1-amine hydrochloride voltam-
metric ionization constant (pKa) value as 9.4. This result
reinforces the previous statements performed on fluoxetine
oxidation peak identification because it is in accordance with
the described pKa value of the drug. Hence, it is valid to assume
that the main oxidative process occurring in fluoxetine is related
to the oxidation of the secondary amine group present in the
molecule structure (Scheme 2). The appearance of the well-
defined shoulder prior to the main oxidation peak in fluoxetine
is probably related to an oxidation step occurring at the
substituted aromatic nucleus yielding an unstable cation-radical
that could undergo further subsequent reactions such as dimer-
ization (Scheme 2). Comparing the voltammetric behavior
observed for the model compounds at pH 8 (Figure 2b), it is
possible to verify a close match between the oxidative signals
obtained for fluoxetine and N-methyl-3-phenylpropan-1-amine
hydrochloride. The wave observed for 1-(benzyloxy)-4-(trif-
luoromethyl)benzene is also consistent in terms of peak
potential, Ep, and peak current, Ip, with the anodic shoulder
verified for fluoxetine (Figure 2b).
The peak potential versus pH data of fluoxetine cyclic
voltammetry studies reinforce the data acquired by DPV. Cyclic
voltammetric experiments showed the irreversible nature of the
oxidation process, because no reduction wave was observed on
the cathodic branch. On increasing the scan rate, the peak
potential shifted to more positive values, a fact that confirms
the irreversible nature of the oxidation process.
The oxidative profile of the main metabolite norfluoxetine
(Scheme 1) was assessed by DPV. Unexpectedly, any note-
worthy oxidative peak was observed over the entire pH range
and potential window studied. Considering the molecular
structure similarities between fluoxetine and norfluoxetine
(Scheme 1) and the previous assumptions, a comparable
oxidative pattern would be expected.
Figure 6. Representation of the most stable conformer calculated for
fluoxetine showing the quasi-perpendicular position of the two aromatic
rings (B3LYP/6-31G** level of calculation).
TABLE 1: Main Geometrical Parameters Presently
Calculated for Base (Fluox) and Salt (Fluox ·HCl) Forms of
Fluoxetine (Isomer S) and Comparison with X-ray Reported
Values for Fluoxetine Hydrochloride
calculateda X-rayb
Fluox (S) Fluox ·HCl (S) Fluox ·HCl
µ (D)c 3.3 23.6
Bond Lengths /pm
C1-N11d 145.8 152.1
C1-C2 153.0 152.5
C3-O4 143.9 142.8
O4-C5 136.4 138.3
C5-C6 140.4 140.0
C3-C13 152.1 151.9
N11-H 101.8 102.6
C1-H 109.6 109.1
C6-H 108.5 108.5
C8-C19 150.0 150.6
C19-F21 135.4 135.1
C6-C18 392.5 392.7
H3-H6 222.6 224.2 228.0
H6-H18 312.6 309.9 281.1
Bond Angles /deg
C12-N11-C1 113.2 114.8
N11-C1-C2 110.7 111.1
C1-C2-C3 113.7 111.3
C2-C3-O4 105.8 104.3
C3-O4-C5 120.2 119.9
O4-C5-C6 115.2 115.0
C5-C6-C7 120.2 119.8
C13-C3-O4 112.3 114.0
C8-C19-F21 111.8 111.4
Dihedral Angles /deg
C12-N11-C1-C2 179.9 -179.4
N11-C1-C2-C3 -176.0 175.9 180.0
C1-C2-C3-C13 174.3 -179.4
C1-C2-C3-O4 -63.1 -56.4 60.6
C13-C3-O4-C5 -77.7 -75.8 75.8
C3-O4-C5-C6 7.4 4.4 -14.5
O4-C5-C6-C7 179.4 178.9
C7-C8-C19-F21 37.5 36.7
H-C3-C2-C1 53.5 60.3
H-C3-C13-C18 30.0 27.0 -19.9
a At the B3LYP/6-31G** level; the values for the unprotonated
species refer to the most stable conformer (I). b From ref 31.
c Dipole moment, in debyes; 1D ) 1/3 × 10-2 Cm. d Atoms are
numbered according to Figure 5A.
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To justify the apparent anodic inactivity of norfluoxetine, a
plausible explanation is herein outlined. In fact, in view of the
peak currents observed for 1-(benzyloxy)-4-(trifluoromethyl)-
benzene (Figures 2b and 3a), it is expected that the norfluoxetine
oxidation process could also lead to a small magnitude wave.
As the oxidative signal is dependent on the kinetics of electron
transfer and diffusion coefficient of the species, the decrease of
the peak height could derive in a loss of sensitivity and
resolution. So, a low signal to background (S/B) ratio can result
that could be regarded as the absence of electroactivity. On the
other hand, norfluoxetine possesses in its molecular structure
an electroactive aliphatic primary amine. However, as primary
amines usually oxidize at potentials higher than that allowed
by the potential window of glassy carbon electrodes, the amine
oxidation signal could not be observed.
To rationalize the apparent discrepancy of fluoxetine and
norfluoxetine results, a complete conformational study of the
drug and its metabolite was performed.
Conformational Analysis. The first step of these studies was
related to the conformational analysis of each fluoxetine
Figure 7. Experimental Raman spectra (2000-3375 cm-1, solid state, 25 °C) for protonated fluoxetine (A), protonated fluoxetine-Nd1 (B), and (A
- B) difference spectrum (C).
9940 J. Phys. Chem. A, Vol. 113, No. 36, 2009 Garrido et al.
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enantiomer. As the conformational preferences were not stere-
odependent (Figure 5A, isomers S and R), the subsequent
investigation was performed for only one enantiomer. Accord-
ingly, a full geometry optimization was then performed for
fluoxetine both in the base and in the salt form. Three distinct
conformations were obtained for the neutral molecule: I, II, and
III (Figure 5A), with relative populations at room temperature
equal to 47.7%, 43.2%, and 9.1%, respectively, while only one
was found for the N-protonated form (Figure 5B). Geometries
I and II interconvert through nitrogen rotation, thus differing
in the orientation of the N-H bond. As for conformer III, it
displays a skewed conformation of the methylpropylamine
TABLE 2: Experimental (Solid State, 25 °C) and Calculated Raman Wavenumbers (cm-1) for Protonated Fluoxetine (Fluox)
and N-Deuterated Protonated Fluoxetine (Fluox-N-d)
experimentala calculatedb
Fluox Fluox-N-d Fluox (S) Fluox (S)-N-d approximate descriptionc
3066 3069 3112 (3; 99) 3112 (3; 99) νs (CH)ring1
3046 3049 3099 (2; 125) 3099 (2; 125) νs (CH)ring1
3014 3016 3097 (2; 59) 3097 (2; 59) νas (CH)ring1
2992 2994 3094 (8; 281) 3094 (8; 281) νs (CH)ring2
2969 3343 (59; 29) νas (NH)
2965 2963 3085 (12; 39) 3083 (5; 51) νas (CH)ring1
2951 2955 3083 (5; 51) 3078 (3; 104) νas (CH)ring2
2939 2941 3074 (0; 74) 3074 (0; 74) νas (CH3)
2920 2922 3050 (1; 22) 3050 (1; 20) νas (CH2)
2873 2907 2976 (0; 65) 2976 (0; 63) νs (CH3)
2847 2876 2932 (10; 59) 2931 (10; 58) νs (CH2)
2832 2836 2896 (19; 52) 2896 (19; 52) ν (CH)
2829 3290 (38; 53) νs (NH)
2827 2830 νs (CH3)
2770 2787 νs (CH2)
2220 2467 (30; 17) νas (ND)
2138 2385 (22; 29) νs (ND)
1617 1618 1608 (104; 54) 1607 (101; 53) ν (CdC)ring1
1603 1604 (39; 7) sciss. (NH2)
1605 1606 1595 (0; 37) 1595 (0; 37) ν (CdC)ring2
1587 1589 1579 (21; 10) 1579 (22; 10) ν (CdC)ring
1471 1465 1463 (14; 13) 1462 (13; 12) δas (CH3) + sciss. (CH2)
1455 1458 1449 (23; 13) 1448 (12; 10) δas (CH3) + sciss. (CH2)
1430 1431 1434 (9; 11) 1446 (22; 14) δas (CH3) + sciss. (CH2)
1393 1403 1411 (3; 2) 1410 (2; 2) δs (CH3)
1359 1362 1350 (14; 12) 1350 (18; 11) ω (CH2) + γ (CH)
1326 1327 1319 (44; 16) 1329 (15; 19) ω (CH2) + γ (CH)
1313 1317 1308 (27; 11) 1309 (29; 7) ν (CdC)ring1 + γ (CH)
1304 1306 1292 (223; 20) 1292 (217; 20) δ (CH)ring1 + ν (C-CF3)
1260 1265 1277 (11; 7) 1275 (9; 12) t (CH2)
1244 1246 1213 (350; 20) 1212 (334; 19) ω (CH2) + t (CH2) + ν (C-O)
1185 1186 1177 (35; 18) 1176 (41; 16) r (CH2) + ν (CdC)ring
1171 1166 (25; 5) sciss (ND2)
1167 1162 (6; 4) r (CH3)
1153 1141 1148 (234; 5) 1148 (235; 5) ν (C-F)
1045 1041 1052 (68; 3) 1051 (76; 3) ν (CdC)ring + ν (C-F)
1010 1015 1014 (2; 14) 1013 (8; 14) ν (CdC)ring + ν (C-C) + ν (C-O)
1002 1003 977 (5; 16) 977 (5; 17) γ (CH)ring
959 948 948 (25; 2) 942 (15; 5) γ (CH)ring + t (CH2) + ν (C-N)
906 890 901 (5; 1) 901 (5; 1) γ (CH)ring
848 851 825 (10; 17) 839 (6; 12) r (CH2) + t (CH2)
819 819 805 (15; 6) 808 (23; 17) r (CH2) + γ (CH)ring
782 783 777 (6; 10) r (CH2) + r (NH2)
747 754 (2; 11) r (CH2) + r (ND2)
732 733 717 (1; 1) 717 (1; 1) δs (CF3) + r (CH2)
650 653 691 (29; 1) 691 (29; 1) γ (CH)ring
638 639 632 (17; 5) 632 (16; 5) ν (CdC)ring1
622 622 607 (1; 4) 611 (7; 3) ν (CdC)ring2 + Γ (COC)
411 415 408 (0; 1) 409 (2; 3) Γ (CCC) + Γ (CNC) + Γ (COC)
361 348 333 (1; 3) 330 (1; 3) ∆ (CCC) + ∆ (CNC) + ∆ (COC)
291 297 305 (4; 1) 304 (4; 1) Γ (CCC) + Γ (CNC) + Γ (COC)
257 259 253 (6; 5) 251 (8; 6) Γ (CCC) + Γ (CNC) + Γ (COC)
215 208 218 (2; 1) 207 (2; 2) τ (CH3)
192 194 184 (2; 4) 184 (2; 3) skeletal mode
171 174 157 (3; 1) 156 (3; 1) skeletal mode
17 (1;1) 16 (1;1) τ (CF3)
a Experimental values obtained for fluoxetine R/S racemic mixture. b Wavenumbers above 400 cm-1 are scaled by a factor of 0.961418 (IR
intensities in km mol-1; Raman scattering activities in Å amu-1). c νs and νas, stretching (symmetric or antissymetric, respectively); δ, in-plane
deformation; t, twisting; r, rocking; ω, wagging; sciss., scissoring; γ, out-of-plane deformation; ∆, in-plane deformation of skeleton atoms; Γ,
out-of-plane deformation of skeleton atoms.
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b
group, 12CH3 and 2CH2 being eclipsed ((C12N11C1C2) ) 0°) as
compared to the conformational preferences presented in I and
II ((C12N11C1C2) ca. 180°).
N-Protonated fluoxetine (Figure 5B) displays particular
conformational features, which correspond to a minimization
of the torsional strain within the molecule: (i) the two aromatic
rings are skewed relative to each other, in an almost perpen-
dicular relative position ((C13C3O4C5) ) -75.8°, (C3O4C5C6)
) 4.4°, (C3O4C5) ) 119.9°, Figure 6), thus hindering any
intramolecular ring-ring stacking interactions, as shown by the
following distances: d(C6 · · ·C18) ) 392.7 pm, d(H6 · · ·H3) )
224.2 pm, and d(H6 · · ·H18) ) 309.9 pm (Table 1); (ii) to
minimize torsional and steric strains, N-methylpropanamine side
chain adopts a staggered (C1-C2 bond) and an antiperiplanar
(between N11 and C3; (N11C1C2C3) ) 175.9°) relationship and
is folded toward the phenoxy moiety ((C1C2C3O4) ) -56.4°,
Figure 6).
The geometrical parameters presently calculated for fluoxetine
hydrochloride agree well with the X-ray data previously reported
for this system (Table 1).31
The same procedure was undertaken for norfluoxetine hy-
drochloride, for which only one geometry for each protonation
state (q ) 0 and q ) +1) was found to occur at room
temperature (Figure 5C). Despite demethylation, this molecule
displays some conformational preferences identical to protonated
fluoxetine ((N11C1C2C3) ) 175.4°, (C1C2C3O4) ) -55.9°,
(C13C3O4C5) ) -75.7°, and (C3O4C5) ) 119.9°, Figure 5C),
except for the (trifluoromethyl)phenoxypropanamine moiety
((C2C3O4C5) ) 159°, (C1C2C3O4) ) -62.0°, and (C3O4C5C6)
) 3.3° vs 161° and -56.4°, 4.4°, respectively, for fluoxetine
(Figure 5)). These conformational differences may be respon-
sible for the distinct electrochemical behavior presently detected
for norfluoxetine, as compared to fluoxetine, because they
markedly influence the transmission of inductive and mesomeric
effects along the molecular system.
Spectroscopic Studies. Figure 7 represents the experimental
Raman solid-state pattern, in the 2000-3500 cm-1 region, for
hydrochloride fluoxetine racemic mixture, both undeuterated
(Figure 7A) and deuterated (Figure 7B). As the harmonic
vibrational frequencies were calculated for each fluoxetine stable
conformer, it was possible to acquire the theoretical vibrational
spectra of the compound as well as the complete assignment of
its experimental Raman bands (Figure 7A, Table 2).
The most characteristic Raman bands detected for solid
hydrochloride fluoxetine may then be grouped as follows
(Figures 7A and 8A, Table 2): (i) NH vibrations, stretching
modes at 2969 and 2829 cm-1, and deformations at 850-650
cm-1; (ii) ring modes, apart from a typical set of three signals
between 655 and 622 cm-1, the most intense ring νCC are
centered at 1617, 1605, and 1010 cm-1; (iii) CH3 modes,
stretching vibrations, as intense bands from ca. 2940 to 2820,
and deformations yielding quite low signals between ca. 1390
and 1470 cm-1, 1143/959 cm-1 (rocking), and 257 cm-1
(torsion); (iv) CF3 modes (giving rise to weak Raman bands),
-C-CF3 and C-F stretchings at 1304 and 1133 cm-1 (respec-
tively), and CF3 out-of-plane deformation at ca. 730 cm-1.
Figure 8. Experimental and calculated Raman spectra (125-1750 cm-1, solid state, 25 °C) for N-protonated fluoxetine (A) and N-protonated
norfluoxetine (B) (solid line, experimental; dotted line, calculated (B3LYP/6-31G**)).
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To better understand the spectroscopic data, the Raman
spectra of the N-deuterated fluoxetine were also obtained. The
Raman pattern of the deuterated drug comprises two νND bands
corresponding to the ND2 group (Figure 7B, Table 2). Actually,
the increase in mass of the ND oscillator relative to NH allows
one to uncover the corresponding stretching modes, which suffer
a large shift to lower wavenumbers, from 2969/2829 to 2220/
2138 cm-1. Consequently, the difference spectrum between the
undeuterated and deuterated samples (Figure 7C) leads to a clear
identification of the two νNH modes, otherwise mixed with the
intense νCH vibrations. This enables a rapid and unequivocal
identification of hydrochloride fluoxetine in a pharmacological
formulation, because it easily allows one to distinguish it from
the excipients or any other compounds present in the solid
mixture.
Apart from the expected downward shift of the NH stretching
modes, fluoxetine deuteration is responsible for some changes
in the vibrations of the terminal methyl group (adjacent to the
deuterated amine), a blue shift of the symmetric deformation
(from 1393 to 1402 cm-1), and a red shift of the rocking and
torsion modes (from 1133 to 1118 cm-1 and 218 to 207 cm-1,
respectively, Table 2). The amine scissoring vibration was also
found to be drastically affected by N-deuteration, δNH ) 1603
cm-1 versus δND ) 1171 cm-1, as predicted by the calculations
(Table 2).
Comparison between the Raman experimental data collected
for fluoxetine hydrochloride and the corresponding calculated
frequencies (after scaling according to Scott and Radom18)
evidences a quite good overall agreement (Figure 8, Table 2).
Actually, the main discrepancies between experimental and
theoretical wavenumbers were detected for those vibrational
modes that are most affected by intermolecular hydrogen
bonds,32 not considered in the theoretical approach presently
used, such as H-type interactions. These close contacts, mainly
involving the N-methyl amine group, are clearly reflected in
the Raman spectra through the large shifts of the νNH and νND
modes to lower wavenumbers as compared to the calculated
values (for the isolated molecule): νNH(exp) ) 2969/2829 cm-1
versus νNH(calc) ) 3343/3290 cm-1, and νND(exp) ) 2220/2138
cm-1 versus νND(calc) ) 2467/2385 (Table 2). This deviation
is less noticeable for the deuterated amine stretching vibrations,
because the (N)D · · ·N(D) close contacts are not as strong as
the (N)H · · ·N(H) ones.
The vibrational data presently obtained also enable one to
distinguish fluoxetine from its main metabolite, norfluoxetine
(Figure 8). In fact, while the former gives rise to characteristic
bands ascribed to the methyl group, δCH3 (from 1390 to 1470
cm-1), rCH3 (at 1167 cm-1), and τCH3 (at 215 cm-1) (Table
2), these are absent in the spectrum of norfluoxetine, which
comprises typical NH3 vibrations instead, such as deformation
modes (between 900 and 1400 cm-1) and τNH3 (at 218 cm-1).
Moreover, the two fluoxetine NH2 stretching vibrations,
observed at 2969 (νas) and 2829 cm-1 (νs), are substituted
by three νNH3 modes (two asymmetric and one symmetric),
around 3000 cm-1.
Conclusions
The well-known antidepressant drug fluoxetine and its
metabolite norfluoxetine were studied as to their electrochemical
behavior and their structural preferences.
The syntheses and study of the electrochemical behavior of
two fluoxetine analogues, 1-(benzyloxy)-4-(trifluoromethyl)ben-
zene and N-methyl-3-phenylpropan-1-amine hydrochloride,
enabled us to conclude that the main oxidative processes
occurring in fluoxetine are related to the oxidation of the
secondary amine group and an oxidation occurring at the
aromatic nucleus, yielding an unstable cation-radical that could
undergo further subsequent reactions such as dimerization.
The conformational analysis carried out for both the proto-
nated and the unprotonated states of the molecules, as well as
for their N-deuterated forms, allowed us to detect conformational
differences between the drug and its metabolite that could
explain the distinct electrochemical behavior presently detected
for norfluoxetine, as compared to fluoxetine. The predicted
vibrational spectra for the most stable calculated conformers
of the systems lead to a complete assignment of the correspond-
ing experimental Raman pattern. The characteristic amine
stretching modes were unequivocally identified, enabling us to
clearly distinguish fluoxetine and norfluoxetine by analysis of
this spectral region.
The results gathered along this work are a valid contribution
to the study and clarification of the effects of pH on bioaccu-
mulation, metabolism, and toxicity of the pharmaceutical drug.
Moreover, the present study evidences the motive for the
reduced use of electroanalytical methods for fluoxetine quan-
tification and points out the utility of Raman spectroscopy as a
high sensitivity and noninvasive technique for a rapid and
reliable characterization of samples.
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